Our study found that SPR965 inhibited cell proliferation and tumor growth by inducing cell cycle G1 arrest and oxidative stress via blocking the PI3K/Akt/mTOR pathway in ovarian cancer. The gene discussed is AKT1; the disease is ovarian carcinoma.